Cleveland Clinic developed Autism Eyes, an eye-tracking technology that detects autism markers by analyzing how children view images. Acquired in early 2024, this technology aims to reduce the typical one-to-three-year delay between noticing symptoms and receiving a formal autism diagnosis.
Cleveland Clinic Innovations (CCI) demonstrated exceptional performance in 2024, securing 144 patents, generating $27 million in licensing revenue, and investing $29 million in companies. The organization's achievements spanned technology development, international expansion, and capital raises, solidifying its position as a transformative force in healthcare innovation.
LifeArc and Cleveland Clinic sign 10-year Master Services Agreement to develop novel monoclonal antibody-based therapeutics, building on their successful collaboration since 2019. The agreement combines LifeArc's three decades of expertise in antibody humanization with Cleveland Clinic's renowned capabilities, aiming to address unmet medical needs in areas including cancer and complement-mediated diseases.
Gerald “Jerry” Wilmink, PhD, MBA, Director, Innovations Business Development and Licensing at Cleveland Clinic Innovations, joined Becker's to discuss how artificial intelligence is revolutionizing healthcare through synthetic data generation, enhanced specialist-generalist collaboration, and improved clinical decision-making capabilities.
JD Friedland shares his journey from investment banking to healthcare innovation leadership, offering insights into Cleveland Clinic Innovations' approach to balancing profitable growth with advancing patient care through strategic investments in digital health, medical devices, and life sciences.
In Cleveland Clinic Innovations’ latest Inventor Chronicle, discover how the Structured Innovation Challenge team "Sac it to ‘Em", featuring Linda Bradley, MD, Bradley Gill, MD, Cara King, DO, MS, Lindsey Valentine, MD, Liron Bar-El, MD, and Emily Frisch, MD, is streamlining specimen bagging with a revolutionary device that enhances efficiency and patient care.
Joseph Iannotti, MD, PhD, Chief Research and Academic Officer at Cleveland Clinic Florida, transformed shoulder surgery through a 15-year research journey that began with a simple anatomical question, developing innovative technologies like preoperative planning software and patient-specific instrumentation. The success of these innovations exemplifies Cleveland Clinic's commitment to reinvesting commercialization gains back into research, creating a virtuous cycle of medical discovery that continuously pushes the boundaries of healthcare innovation.
Cleveland Clinic physicians Matthew Kroh, MD, Xiaoxi (Chelsea) Feng, MD, MPH, and Ricard Corcelles, MD, share how their Structured Innovation Challenge team, The Abdominal Innovators, which also included Salvador Navarrete, MD, and Andrew Strong, MD, are revolutionizing surgical precision with their work on a minimally invasive measurement instrument, as featured in Cleveland Clinic Innovations’ Inventor Chronicle series.
The Innovation Challenge showcased three groundbreaking medical technologies addressing challenges in weight management, bacterial infections, and heart valve repair. Jeannette Messer, DVM, PhD, was awarded the $100,000 prize from Jones Day for her innovative antimicrobial antibody therapeutics that could revolutionize how bacterial infections are treated.
By Gerald “Jerry” Wilmink, PhD, MBA, Director, Innovations Business Development and Licensing